Managed Healthcare Executive February 1, 2025
Denise Myshko

In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.

Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes, according to new research from the University of Virginia Center for Diabetes Technology. Researchers said this could save patients with type 1 diabetes from experiencing blindness and diabetic neuropathy and other complications.

Researchers wanted to determine whether time-in-range (TIR) could be a viable marker of glycemic control. Time in range that has not been established as a surrogate marker for a clinical outcome, and researchers pointed out that the FDA has...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Technology, Wearables
Beat The Noise, What the Apple Noise Cancellation Story Gets Right
Sibel Health Rakes In $30M for Its Wearable-Based RPM Platform
Smartwatch data: Study finds early health differences in long COVID patients
Q&A: Oura appoints its first chief medical officer
CGM Could Help Management of Diabetic Ketoacidosis

Share This Article